However, this approach is off-label and not supported by clinical trial data
Patients with baseline blood glucose above 200 mg/dL often notice dramatic drops within the first two weeks, while those with milder elevations may see more gradual declines
But where semaglutide acts on one receptor (the glucagon-like peptide-1, or GLP-1, receptor), and tirzepatide on two (GLP-1 and the gastric inhibitory polypeptide, or GIP, receptors), retatrutide has been nicknamed Triple G for its ability to work on three hormone receptors (those for GLP-1 and GIP, as well as the glucagon, or GCG, receptor)
Four of the articles reviewed showed that there was increased incidence of aspiration among GLP-1 RA users (Australian Diabetes Society, National Association of Clinical Obesity Services, Gastroenterological Society of Australia, and Australian and New Zealand College of Anaesthetists n.d.)
Should I ask for a stomach protector if Im using NSAIDs regularly on Wegovy